Home Cart 0 Sign in  
X

[ CAS No. 618-89-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 618-89-3
Chemical Structure| 618-89-3
Chemical Structure| 618-89-3
Structure of 618-89-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 618-89-3 ]

Related Doc. of [ 618-89-3 ]

Alternatived Products of [ 618-89-3 ]

Product Details of [ 618-89-3 ]

CAS No. :618-89-3 MDL No. :MFCD00017777
Formula : C8H7BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :KMFJVYMFCAIRAN-UHFFFAOYSA-N
M.W : 215.04 Pubchem ID :12070
Synonyms :

Calculated chemistry of [ 618-89-3 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 45.42
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.55 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.34
Log Po/w (XLOGP3) : 2.91
Log Po/w (WLOGP) : 2.24
Log Po/w (MLOGP) : 2.67
Log Po/w (SILICOS-IT) : 2.36
Consensus Log Po/w : 2.5

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.28
Solubility : 0.113 mg/ml ; 0.000527 mol/l
Class : Soluble
Log S (Ali) : -3.12
Solubility : 0.162 mg/ml ; 0.000753 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.33
Solubility : 0.0999 mg/ml ; 0.000465 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.42

Safety of [ 618-89-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 618-89-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 618-89-3 ]
  • Downstream synthetic route of [ 618-89-3 ]

[ 618-89-3 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 618-89-3 ]
  • [ 618-91-7 ]
  • [ 1751-97-9 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1980, vol. 53, # 12, p. 3691 - 3695
  • 2
  • [ 618-89-3 ]
  • [ 39115-96-3 ]
Reference: [1] Journal of the Chilean Chemical Society, 2012, vol. 57, # 4, p. 1492 - 1496
[2] Patent: WO2009/54923, 2009, A2, . Location in patent: Page/Page column 29; 30; 31
[3] Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 2010, vol. 65, # 2, p. 178 - 184
[4] Monatshefte fur Chemie, 2010, vol. 141, # 4, p. 479 - 484
[5] Medicinal Chemistry, 2012, vol. 8, # 6, p. 1190 - 1197,8
[6] Medicinal Chemistry, 2012, vol. 8, # 6, p. 1190 - 1197
[7] Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 2015, vol. 70, # 8, p. 609 - 616
[8] Bulletin of the Korean Chemical Society, 2012, vol. 33, # 12, p. 3943 - 3949
[9] Bulletin of the Korean Chemical Society, 2012, vol. 33, # 12, p. 4180 - 4184
[10] Chemical Biology and Drug Design, 2013, vol. 82, # 5, p. 546 - 556
[11] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 1, p. 192 - 194
[12] Chemical Communications, 2015, vol. 51, # 76, p. 14365 - 14368
[13] Journal of Molecular Structure, 2016, vol. 1117, p. 8 - 16
[14] Letters in Drug Design and Discovery, 2016, vol. 13, # 9, p. 968 - 981
[15] Chemical Biology and Drug Design, 2017, vol. 89, # 1, p. 47 - 60
  • 3
  • [ 928664-98-6 ]
  • [ 618-89-3 ]
  • [ 68432-92-8 ]
YieldReaction ConditionsOperation in experiment
69% With potassium fluoride; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 In dimethyl sulfoxide at 130℃; for 18 h; Inert atmosphere; Sealed tube Step 1: To a vial with a stir bar was added methyl 3-bromobenzoate (1.0 equiv.) 4-isoxazoleboronic acid (1.2 equiv.), PdCl2(dppf).CH2Cl2 adduct (0.1 equiv.), 1M KF (2.0) and DMSO (0.10 M). The reaction mixture was degassed with bubbling nitrogen and the vial capped and heated at 130° C. for 18 hr. LCMS analysis indicated the formation of the desired product (MH+-176, Rt—0.62 min). The reaction mixture was diluted with a saturated solution of NH4Cl and extracted with EtOAc (2×). The combined organics were washed with water and brine, dried over MgSO4, filtered and concentrated. The crude material was purified via flash chromatography over silica gel eluting with heptanes and 0-100percent ethyl acetate gradient. Isolated methyl 3-(cyanomethyl)benzoate in 69percent yield. LCMS (m/z) (M+H)=176.1, Rt=0.62). 1H NMR (400 MHz, ) δ ppm 3.92 (s, 3H), 3.99 (s, 2H), 7.49-7.55 (m, 1H), 7.62 (d, J=7.83 Hz, 1H), 7.99 (d, J=7.83 Hz, 1H), 8.04 (s, 1H).
Reference: [1] Patent: US2014/275003, 2014, A1, . Location in patent: Paragraph 0182
  • 4
  • [ 618-89-3 ]
  • [ 68432-92-8 ]
Reference: [1] Patent: CN106928092, 2017, A,
  • 5
  • [ 618-89-3 ]
  • [ 15852-73-0 ]
Reference: [1] Catalysis Science and Technology, 2017, vol. 7, # 6, p. 1297 - 1304
[2] Organic Letters, 2016, vol. 18, # 15, p. 3894 - 3897
  • 6
  • [ 618-89-3 ]
  • [ 75-16-1 ]
  • [ 30951-66-7 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: at 6 - 20℃; for 3.66667 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; diethyl ether; water at 0℃;
EXAMPLE 76; Preparation of N- [ (lS, 2R)-3- { [l- (3-bromophenyl)-l- methylethyl] amino}-1- (3, 5-difluorobenzyl)-2-hydroxypropyl] acetamide; 32 Scheme 8 O Br MeMgBr g NaN3 Br '°H Bu OMe OH Nh THF TFA THF 4 | kOH SOH 4 reflux H 19 H HOH H N, 1) TFA-0 zon F F 0 HCI 2) Ac-Im F 31 3) HCI 30 30 F 31 F NaOH HOH H Bu F 32 Step 1; Preparation of 2- (3-bromophenyl)-2-propanol 27; To 75 mmol of methylmagnesium bromide in 25 mL of ether stirring at 6 °C is added, dropwise over 10 min, a solution of methyl-3-bromobenzoate (4.3 g, 20 mmol) in 25 mL of dry THF. The mixture is then allowed to warm to ambient temperature and stirred for 3.5 h, then cooled to 0°C and quenched by dropwise addition of aqueous 10percent HC1. The acidified mixture is extracted twice with ethyl acetate, and the combined organic phases are washed with 1 N NaHC03 and with brine. The solution is dried over Na2SO4, concentrated, and chromatographed over silica gel, eluting with 15percent ethyl acetate in heptane, to afford 4.00 g (18.6 mmol, 93percent) of 2- (3-bromophenyl)-2- propanol 27 as a pale yellow oil
14.9 g at -78 - 20℃; for 2 h; To a solution of methyl 3-bromobenzoate (15.0 g, 69.8 mmol) in THF (140 mL) at -78 °C was added dropwise a solution of MeMgBr/diethyl ether [3.0M] (58 mL). The reaction mixture was warmed up to room temperature and stirred for 2 h. The solution was poured to an aqueous saturated solution of ammonium chloride and the organic material was extracted with EtOAc. The organic layer was dried over Na2S04, filtered and concentrated to afford the corresponding alcohol (14.9 g) which was used without further purification.
14.9 g at -78 - 20℃; for 2 h; To a solution of methyl 3-bromobenzoate (15.0 g, 69.8 mmol) in THF (140 mL) at −78° C. was added dropwise a solution of MeMgBr/diethyl ether [3.0M] (58 mL). The reaction mixture was warmed up to room temperature and stirred for 2 h. The solution was poured to an aqueous saturated solution of ammonium chloride and the organic material was extracted with EtOAc. The organic layer was dried over Na2SO4, filtered and concentrated to afford the corresponding alcohol (14.9 g) which was used without further purification.
Reference: [1] Patent: WO2005/95326, 2005, A2, . Location in patent: Page/Page column 189-190
[2] Journal of Organic Chemistry, 1960, vol. 25, # 10, p. 1691 - 1693
[3] Patent: WO2005/70932, 2005, A2, . Location in patent: Page/Page column 51
[4] Patent: WO2015/89067, 2015, A1, . Location in patent: Page/Page column 122
[5] Patent: US9126993, 2015, B2, . Location in patent: Page/Page column 50
  • 7
  • [ 618-89-3 ]
  • [ 74-88-4 ]
  • [ 30951-66-7 ]
YieldReaction ConditionsOperation in experiment
4.98 g
Stage #1: With magnesium In diethyl etherReflux
Stage #2: for 3 h; Reflux
A solution of methylmagnesium iodide is prepared from 5.79 ml of methyl iodide and 2.2 g of magnesium turnings in refluxing ether. A solution of 5 g of methyl 3- bromobenzoate in 110 ml of ether is then added dropwise and the mixture is refluxed for 3 hours. The reaction mixture is poured onto ice/saturated NH4C1, the phases are separated by settling, the organic phase is washed with 10percent aHC03 solution and with saturated NaCl solution, and dried over MgS04, and the solvent is evaporated off under vacuum. 4.98 g of the expected compound are obtained.
Reference: [1] Patent: WO2013/87643, 2013, A1, . Location in patent: Page/Page column 15
  • 8
  • [ 618-89-3 ]
  • [ 10602-06-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 6, p. 1475 - 1486
[2] Journal of Organic Chemistry, 1985, vol. 50, # 10, p. 1763 - 1765
[3] Journal of Organic Chemistry, 1981, vol. 46, # 11, p. 2280 - 2286
[4] Journal of the American Chemical Society, 2013, vol. 135, # 22, p. 8400 - 8408
[5] Molecules, 2018, vol. 23, # 8,
  • 9
  • [ 618-89-3 ]
  • [ 10601-99-7 ]
Reference: [1] Patent: WO2014/168824, 2014, A1,
  • 10
  • [ 618-89-3 ]
  • [ 13411-48-8 ]
  • [ 21860-07-1 ]
Reference: [1] Organic Letters, 2014, vol. 16, # 3, p. 824 - 827
  • 11
  • [ 618-89-3 ]
  • [ 21860-07-1 ]
Reference: [1] Patent: WO2008/65508, 2008, A1,
  • 12
  • [ 618-89-3 ]
  • [ 52787-19-6 ]
Reference: [1] Patent: CN106928092, 2017, A,
  • 13
  • [ 618-89-3 ]
  • [ 99769-19-4 ]
Reference: [1] Organic Letters, 2012, vol. 14, # 18, p. 4814 - 4817,4
  • 14
  • [ 618-89-3 ]
  • [ 73183-34-3 ]
  • [ 269409-73-6 ]
Reference: [1] Synthesis (Germany), 2012, vol. 44, # 14, p. 2173 - 2180
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 618-89-3 ]

Aryls

Chemical Structure| 619-42-1

[ 619-42-1 ]

Methyl 4-bromobenzoate

Similarity: 0.98

Chemical Structure| 127437-29-0

[ 127437-29-0 ]

Diethyl 5-bromoisophthalate

Similarity: 0.96

Chemical Structure| 104901-43-1

[ 104901-43-1 ]

Methyl 3-bromo-4-methylbenzoate

Similarity: 0.96

Chemical Structure| 148547-19-7

[ 148547-19-7 ]

Methyl 4-bromo-3-methylbenzoate

Similarity: 0.96

Chemical Structure| 877624-40-3

[ 877624-40-3 ]

Methyl 3-bromo-5-(bromomethyl)benzoate

Similarity: 0.94

Bromides

Chemical Structure| 619-42-1

[ 619-42-1 ]

Methyl 4-bromobenzoate

Similarity: 0.98

Chemical Structure| 127437-29-0

[ 127437-29-0 ]

Diethyl 5-bromoisophthalate

Similarity: 0.96

Chemical Structure| 104901-43-1

[ 104901-43-1 ]

Methyl 3-bromo-4-methylbenzoate

Similarity: 0.96

Chemical Structure| 148547-19-7

[ 148547-19-7 ]

Methyl 4-bromo-3-methylbenzoate

Similarity: 0.96

Chemical Structure| 64169-34-2

[ 64169-34-2 ]

5-Bromoisobenzofuran-1(3H)-one

Similarity: 0.94

Esters

Chemical Structure| 619-42-1

[ 619-42-1 ]

Methyl 4-bromobenzoate

Similarity: 0.98

Chemical Structure| 127437-29-0

[ 127437-29-0 ]

Diethyl 5-bromoisophthalate

Similarity: 0.96

Chemical Structure| 104901-43-1

[ 104901-43-1 ]

Methyl 3-bromo-4-methylbenzoate

Similarity: 0.96

Chemical Structure| 148547-19-7

[ 148547-19-7 ]

Methyl 4-bromo-3-methylbenzoate

Similarity: 0.96

Chemical Structure| 64169-34-2

[ 64169-34-2 ]

5-Bromoisobenzofuran-1(3H)-one

Similarity: 0.94